Bill

Bill > HB481


KY HB481

KY HB481
AN ACT relating to kratom products.


summary

Introduced
02/12/2025
In Committee
02/14/2025
Crossed Over
Passed
Dead
03/28/2025

Introduced Session

2025 Regular Session

Bill Summary

Amend KRS 217.2202 to eliminate the prohibition on kratom extracts and kratom products that contain greater than two percent 7-hydroxymitragynine; amend KRS 217.2203 to establish that products that contain greater than two percent 7-hydroxymitragynine shall comply with labeling requirements for kratom products but shall not be labeled or marketed as a kratom product; amend KRS 217.2205 to establish that that products that contain greater than two percent 7-hydroxymitragynine shall be subject to administrative regulations promulgated by the Department for Public Health, except the department shall not require those products to be labeled as a kratom product or as containing kratom extracts.

AI Summary

This bill modifies existing Kentucky law regarding kratom products by eliminating the previous prohibition on kratom extracts containing more than 2% 7-hydroxymitragynine (a specific alkaloid compound found in kratom). The bill establishes new requirements for products with high levels of 7-hydroxymitragynine, mandating that they must comply with labeling standards similar to traditional kratom products, but with a key distinction: these high-potency products cannot be labeled or marketed as kratom products. The legislation maintains existing consumer protection provisions, such as prohibiting sales to individuals under 21 and preventing the distribution of adulterated or dangerous kratom products. Specifically, the bill requires clear labeling of ingredients, mitragynine and 7-hydroxymitragynine content, serving sizes, vendor information, and safety disclaimers for all kratom-related products. The Department of Public Health is authorized to create administrative regulations for these products, with the stipulation that regulations cannot require high-potency products to be labeled specifically as kratom products. This approach appears to create a regulatory framework that acknowledges the existence of more concentrated kratom extracts while maintaining consumer safety standards.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

to Health Services (H) (on 02/14/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...